530 related articles for article (PubMed ID: 26391395)
1. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells.
Agarwal S; Bell CM; Rothbart SB; Moran RG
J Biol Chem; 2015 Nov; 290(46):27473-86. PubMed ID: 26391395
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
3. Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas.
Rothbart SB; Racanelli AC; Moran RG
Cancer Res; 2010 Dec; 70(24):10299-309. PubMed ID: 21159649
[TBL] [Abstract][Full Text] [Related]
4. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia.
Wolff NC; Vega-Rubin-de-Celis S; Xie XJ; Castrillon DH; Kabbani W; Brugarolas J
Mol Cell Biol; 2011 May; 31(9):1870-84. PubMed ID: 21383064
[TBL] [Abstract][Full Text] [Related]
5. Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage.
Habib SL; Yadav A; Kidane D; Weiss RH; Liang S
Cell Cycle; 2016 Nov; 15(22):3048-3059. PubMed ID: 27611085
[TBL] [Abstract][Full Text] [Related]
6. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
Zajkowicz A; Rusin M
Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
[TBL] [Abstract][Full Text] [Related]
7. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
8. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
9. Energy depletion of bovine mammary epithelial cells activates AMPK and suppresses protein synthesis through inhibition of mTORC1 signaling.
Burgos SA; Kim JJ; Dai M; Cant JP
Horm Metab Res; 2013 Mar; 45(3):183-9. PubMed ID: 22972179
[TBL] [Abstract][Full Text] [Related]
10. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
Chen MB; Shen WX; Yang Y; Wu XY; Gu JH; Lu PH
J Cell Physiol; 2011 Jul; 226(7):1915-25. PubMed ID: 21506122
[TBL] [Abstract][Full Text] [Related]
11. Lipid-induced mTOR activation in rat skeletal muscle reversed by exercise and 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside.
Rivas DA; Yaspelkis BB; Hawley JA; Lessard SJ
J Endocrinol; 2009 Sep; 202(3):441-51. PubMed ID: 19574345
[TBL] [Abstract][Full Text] [Related]
12. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
13. Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.
Racanelli AC; Rothbart SB; Heyer CL; Moran RG
Cancer Res; 2009 Jul; 69(13):5467-74. PubMed ID: 19549896
[TBL] [Abstract][Full Text] [Related]
14. Curcumin disrupts the Mammalian target of rapamycin-raptor complex.
Beevers CS; Chen L; Liu L; Luo Y; Webster NJ; Huang S
Cancer Res; 2009 Feb; 69(3):1000-8. PubMed ID: 19176385
[TBL] [Abstract][Full Text] [Related]
15. mTORC1 silencing during intestinal epithelial Caco-2 cell differentiation is mediated by the activation of the AMPK/TSC2 pathway.
Kaur H; Moreau R
Biochem Biophys Res Commun; 2021 Mar; 545():183-188. PubMed ID: 33561653
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.
Imamura K; Ogura T; Kishimoto A; Kaminishi M; Esumi H
Biochem Biophys Res Commun; 2001 Sep; 287(2):562-7. PubMed ID: 11554766
[TBL] [Abstract][Full Text] [Related]
17. p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.
Agarwal S; Bell CM; Taylor SM; Moran RG
Mol Cancer Res; 2016 Jan; 14(1):66-77. PubMed ID: 26385560
[TBL] [Abstract][Full Text] [Related]
18. Capsaicin induces apoptosis in human osteosarcoma cells through AMPK-dependent and AMPK-independent signaling pathways.
Ying H; Wang Z; Zhang Y; Yang TY; Ding ZH; Liu SY; Shao J; Liu Y; Fan XB
Mol Cell Biochem; 2013 Dec; 384(1-2):229-37. PubMed ID: 24005536
[TBL] [Abstract][Full Text] [Related]
19. Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.
Al-Moujahed A; Nicolaou F; Brodowska K; Papakostas TD; Marmalidou A; Ksander BR; Miller JW; Gragoudas E; Vavvas DG
Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4175-85. PubMed ID: 24781943
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
